Venkat Rao Gadhachanda

This inventor holds 66 USPTO granted patents and 20 published patent applications, plus 1 CIPO patent and 17 EPO patents, primarily in Pharmaceutical Compounds (CPC class C07D). Top assignee: Achillion Pharmaceuticals, Inc.. Active years: 2012-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Venkat Rao Gadhachanda. Retrieved from https://idiyas.com/inventor/venkat-rao-gadhachanda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 66 (Patent Applications = 20)

% Patents Active = 80.3

CIPO Patents = 1 (Patent Applications = 7)

EPO Patents = 17 (Patent Applications = 26)

Average Co-Inventor Count = 8.7

ph-index = 22

Forward Citations = 930(Granted Patents)

Forward Citations (Not Self Cited) = 178(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

66 out of 104

Achillion Pharmaceuticals, Inc.

patents

Years Active: 2012-2025

Loading Chart...

Areas of Expertise:

Pharmaceutical Compounds

Aryl Compounds

Macrocyclic Compounds

Heteroaryl Compounds

Inflammatory Disorders

Complement Mediated Disorders

Medical Disorders

Amino Compounds

Amide Compounds

Disubstituted Compounds

Ether Compounds

Phosphonate Compounds

66 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12479856 - Pharmaceutical compounds for the treatment of complement mediated disorders (2025-11-25),

2. 12338230 - Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders (2025-06-24),

3. 12297205 - Macrocyclic compounds for treatment of medical disorders (2025-05-13),

4. 12162860 - Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders (2024-12-10),

5. 12139497 - Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders (2024-11-12),

6. 12065459 - Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders (2024-08-20),

7. 12006307 - Pharmaceutical compounds for treatment of medical disorders (2024-06-11),

8. 11926617 - Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders (2024-03-12),

9. 11814391 - Macrocyclic compounds for the treatment of medical disorders (2023-11-14),

10. 11718626 - Macrocyclic compounds for treatment of medical disorders (2023-08-08),

11. 11708351 - Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders (2023-07-25),

12. 11649229 - Amide compounds for treatment of immune and inflammatory disorders (2023-05-16),

13. 11649223 - Amino compounds for treatment of immune and inflammatory disorders (2023-05-16),

14. 11447465 - Pharmaceutical compounds for treatment of medical disorders (2022-09-20),

15. 11407738 - Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders (2022-08-09),

Title: The Innovative Mind of Venkat Rao Gadhachanda

Introduction:

Venkat Rao Gadhachanda is a visionary inventor based in Hamden, CT (US) known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

Venkat Rao Gadhachanda holds several patents in various technological domains, showcasing his versatility and creativity in inventing new solutions to complex problems.

Career Highlights:

Throughout his illustrious career, Venkat Rao Gadhachanda has consistently pushed the boundaries of innovation, leading to the development of cutting-edge technologies that have revolutionized industries.

Collaborations:

Venkat Rao Gadhachanda has collaborated with leading research institutions, universities, and companies to bring his inventions to life, fostering a culture of innovation and collaboration in the tech community.

Conclusion:

In conclusion, Venkat Rao Gadhachanda's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors, inspiring future generations to think outside the box and create a better tomorrow.

Profile summary based on public USPTO records.